Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer
Leen
L
Van Limbergen
Erik
E
De Nys
Katelijne
K
Moerman
Philippe
P
Pochet
Nathalie
N
Hendrickx
Wouter
W
Wildiers
Hans
H
Paridaens
Robert
R
Smeets
Ann
A
Christiaens
Marie-Rose
MR
Vergote
Ignace
I
Leunen
Karin
K
Amant
Frederic
F
Neven
Patrick
P
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D010641:Phenotype; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D015996:Survival Rate; D016896:Treatment Outcome
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone